R
R

RossStores

News

U.S. STOCKS Terns Pharma, Rivian, Intel, Micron

BUZZ-U.S. STOCKS ON THE MOVE-Terns Pharma, Rivian, Intel, Micron Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street indexes rose on Wednesday as worries about stress in the banking sector eased, with some upbeat earnings reports and rising expectations about the Federal Reserve pausing interest rate hikes boosting sentiment further.
B
C
C
J
L
M
R
M

U.S. STOCKS Nikola, Cintas, Seagate

BUZZ-U.S. STOCKS ON THE MOVE-Nikola, Cintas, Seagate Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street indexes rose on Wednesday as worries about stress in the banking sector eased, with some upbeat earnings reports and rising expectations about the Federal Reserve pausing interest rate hikes boosting sentiment further.
A
B
C
C
C
C
F
I
J
L
M
R
R
U
U
F
F
M

Ross Stores Announces 8% Increase In Quarterly Cash Dividend

BRIEF-Ross Stores Announces 8% Increase In Quarterly Cash Dividend Feb 28 (Reuters) - Ross Stores Inc ROST.O : ROSS STORES - PLANNING 2023 COMPARABLE STORE SALES TO BE RELATIVELY FLAT VERSUS 4% DECLINE & 13% GAIN IN FISCAL 2022 & 2021, RESPECTIVELY ROSS STORES REPORTS FOURTH QUARTER AND FISCAL 2022 RESULTS ANNOUNCES 8% INCREASE IN QUARTERLY CASH DI
R

Ross Stores Reports Fourth Quarter And Fiscal 2022 Results

BRIEF-Ross Stores Reports Fourth Quarter And Fiscal 2022 Results Feb 28 (Reuters) - Ross Stores Inc ROST.O : ROSS STORES REPORTS FOURTH QUARTER AND FISCAL 2022 RESULTS ANNOUNCES 8% INCREASE IN QUARTERLY CASH DIVIDEND EARNINGS PER SHARE FOR Q4 ENDED JANUARY 28, 2023 OF $1.31 EXPECT EARNINGS PER SHARE FOR 53 WEEKS ENDING FEBRUARY 3, 2024 TO BE $4.65
R

U.S. earnings week ahead

DIARY-U.S. earnings week ahead Feb 24 (Reuters) - Diary of U.S. (.SPX) corporate earnings for the week ahead. ** Please Note - All times given are in U.S. EDT unless otherwise stated ** U.S. EARNINGS Start Date Start Time RIC Company Name Event Name 27-Feb-2023 AMC UHS Universal Health Services Inc Q4 2022 Universal Health Services Inc Earnings Release 27-Feb-2023 AMC OKE ONEOK Inc Q4 2022 ONEOK Inc Earnings Release 27-Feb-2023 AMC OXY Occidental Petroleum Corp Q4 2022 Occidental Petroleum Corp
A
B
C
K
M
S
V
D
D
R
U
A
C
P
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.